Liposome
Liposomes (NPs typically 100–500 nm in diameter) are fabricated from the self-assembly of phospholipids, which consist of a polar phosphate head group and hydrophobic lipid tails. In aqueous environments, the hydrophobic tails self-orient, resulting in a spherical structure comprised of an aqueous core surrounded by a lipophilic bilayer membrane. Liposomes are both biocompatible and biodegradable (e.g., at certain pH and temperature), which can be controlled by modifying the lipid composition. Furthermore, liposomes are amenable to various modifications that improve their efficacy as drug delivery carriers.
All Product Categories
-
Liposome Related Products (1265)
Related Products (1265)
-
DSPE-PEG-Carboxylic acid ammonium
0 ImagesCat. No.: HY-144001CAS No.: 474922-20-8DSPE-PEG-Carboxylic acid ammonium is a phospholipid PEG conjugate. DSPE-PEG-Carboxylic Acid can be widely used in the delivery of targeted agents and genes.
-
DMG-PEG2000-Alkyne
0 ImagesCat. No.: HY-183191ADMG-PEG2000-Alkyne is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and a terminal alkyne group. DMG-PEG2000-Alkyne combines the membrane compatibility of phospholipids with the high reactivity of the alkyne group in click chemistry, making it suitable for research in biomaterial construction and drug delivery.
-
2,3-Dipalmitoyl-sn-glycero-1-phosphocholine, 99%
0 ImagesCat. No.: HY-W127459ACAS No.: 35418-55-4Synonyms: D-DPPC, 99%2,3-Dipalmitoyl-sn-glycero-1-phosphocholine, 99% (D-DPPC, 99%) is a chiral phospholipid that serves as a membrane-forming lipid component for bicelle assembly. 2,3-Dipalmitoyl-sn-glycero-1-phosphocholine, 99% can form bicelle assemblies with DHPC, which induce an induced circular dichroism (ICD) signal in the chiral probe DPH, with a polarity opposite to that induced by chiral L-DPPC/DHPC bicelles.
-
DLPG
0 ImagesCat. No.: HY-W800733CAS No.: 73548-69-3Synonyms: 1,2-Dilauroyl-sn-glycero-3-phosphorylglycerol; PG(12:0/12:0)DLPG is a phospholipid containing lauric acid (12 chain fatty acid) inserted at the sn-1 and sn-2 positions. Its phosphate group is attached to glycerol. It is used in the generation of micelles, liposomes, and other artificial membranes.
-
DSG-PEG2000-Glucose
0 ImagesCat. No.: HY-183159ADSG-PEG2000-Glucose is a conjugate composed of DSG, a PEG chain, and terminal glucose. DSG-PEG2000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
-
DLPE-mPEG2000
0 ImagesCat. No.: HY-W1130412CAS No.: 2742671-71-0DLPE-mPEG2000 is an amphiphilic phospholipid-modified polymer that can be used to prepare lipid nanoparticles or liposomes for targeted drug delivery applications.
-
DSG-PEG1000-Mal
0 ImagesCat. No.: HY-183126DSG-PEG1000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
-
DSPE-PEG1000-CTP
0 ImagesCat. No.: HY-182095DSPE-PEG1000-CTP is a PEG compound which composed of DSPE and a Cardiac-targeting peptide CTP (HY-P4094). CTP molecules that specifically recognize cardiac tissue and is primarily used for targeted drug delivery. CTP effectively recognizes and binds to specific receptors on the surface of cardiac cells, thereby achieving precise localization of drug molecules. DSPE-PEG1000-CTP can be used for drug delivery.
-
DOPE-PEG2000-NHS
0 ImagesCat. No.: HY-203300DOPE-PEG2000-NHS is a conjugate composed of DOPE, PEG chains, and terminal active ester (NHS). The NHS ester in DOPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptide chains, and small molecules modified with amino groups) to form stable amide bonds, suitable for the construction of carriers requiring membrane fusion properties or pH-sensitive release (such as gene delivery systems).
-
Lipid C16-C
0 ImagesCat. No.: HY-W1130452CAS No.: 2639634-86-7Lipid C16-C is an ionizable cationic lipid that can be used to prepare lipid nanoparticles (LNPs) for mRNA delivery. Lipid C16-C mediates ApoE-independent macropinocytosis-based mRNA delivery to macrophages, with endosomal acidification enabling endosomal escape and release of mRNA cargo into the cytosol.
-
Phospholipid-PEG1000-Biotin
0 ImagesCat. No.: HY-147207Phospholipid-PEG1000-Biotin is a phospholipid PEG derivative that has a biotin and a phospholipid bridged by a linear PEG linker. Phospholipid-PEG1000-Biotin can interact with avidinylated antibodies. Phospholipid-PEG1000-Biotin can be used to modify liposome and cells surface, and pancreatic islets for cell transplantation.
-
PtdIns-(3,4,5)-P3(1,2-dihexanoyl) ammonium
0 ImagesCat. No.: HY-141420CAS No.: 799268-62-5PtdIns-(3,4,5)-P3(1,2-dihexanoyl) ammonium (compound 850176) is a vaccine adjuvant that enhances the immune function of vaccines.
-
FTT5 LLNs
0 ImagesCat. No.: HY-153138CAS No.: 2803606-43-9FTT5 LLNs are functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing.
-
DSPE-PEG3400-YIGSR
0 ImagesCat. No.: HY-172476ADSPE-PEG3400-YIGSR is a PEG compound which composed of DSPE and a biomimetic peptide YIGSR. YIGSR interacts with the 67 kDa laminin binding protein (LBP) and promotes adhesion and spreading of a large number of cell types including endothelial cells, fibroblasts and smooth muscle cells. DSPE-PEG3400-YIGSR can be used for drug delivery.
-
Bis-DSPE PEG2000 sodium
0 ImagesCat. No.: HY-N16038CAS No.: 2260795-82-0Bis-DSPE PEG2000 sodium is a PEG polymer containing DSPE and amine end groups. Bis-DSPE PEG2000 sodium can be used to synthesize lipid nanoparticles for drug delivery.
-
18:2 TAP chloride
0 ImagesCat. No.: HY-179745CAS No.: 1169768-16-418:2 TAP (chloride) is a cationic lipid .
-
31hP
0 ImagesCat. No.: HY-17195131hP is an asymmetric A3 lipid. 31hP can facilitate in vivo luciferase expression. 31hP can be rapidly degraded in the presence of esterase owing to two biocleavable ester bonds. 31hP can be used in the synthesis of lipid nanoparticles (LNPs).
